Knockdown of vps54 aggravates tamoxifen-induced cytotoxicity in fission yeast |
Lee, Sol
(Department of New Drug Development, Chungnam National University)
Nam, Miyoung (Department of New Drug Development, Chungnam National University) Lee, Ah-Reum (Department of New Drug Development, Chungnam National University) Baek, Seung-Tae (Department of New Drug Development, Chungnam National University) Kim, Min Jung (Department of New Drug Development, Chungnam National University) Kim, Ju Seong (Department of New Drug Development, Chungnam National University) Kong, Andrew Hyunsoo (Morrissey College of Arts and Sciences, Boston College) Lee, Minho (Department of Life Science, Dongguk University-Seoul) Lee, Sook-Jeong (Department of Bioactive Material Science, Jeonbuk National University) Kim, Seon-Young (Personalized Medicine Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB)) Kim, Dong-Uk (Rare Disease Research Center, Korea Research Institute of Bioscience & Biotechnology(KRIBB)) Hoe, Kwang-Lae (Department of New Drug Development, Chungnam National University) |
1 | Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003;2:205-213. DOI |
2 | Wagner EM, Gallagher SJ, Reddy S, Mitzner W. Effects of tamoxifen on ischemia-induced angiogenesis in the mouse lung. Angiogenesis 2003;6:65-71. DOI |
3 | Altan N, Chen Y, Schindler M, Simon SM. Tamoxifen inhibits acidification in cells independent of the estrogen receptor. Proc Natl Acad Sci U S A 1999;96:4432-4437. DOI |
4 | Chang Y, Lee JJ, Chen WF, Chou DS, Huang SY, Sheu JR. A novel role for tamoxifen in the inhibition of human platelets. Transl Res 2011;157:81-91. DOI |
5 | Han S, Lee M, Chang H, Nam M, Park HO, Kwak YS, et al. Construction of the first compendium of chemical-genetic profiles in the fission yeast Schizosaccharomyces pombe and comparative compendium approach. Biochem Biophys Res Commun 2013;436:613-618. DOI |
6 | Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006;126:611-625. DOI |
7 | Iorns E, Lord CJ, Ashworth A. Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. Biochem J 2009;417:361-370. DOI |
8 | Kim DU, Hayles J, Kim D, Wood V, Park HO, Won M, et al. Analysis of a genome-wide set of gene deletions in the fission yeast Schizosaccharomyces pombe. Nat Biotechnol 2010;28:617-623. DOI |
9 | Haridas V. Tailoring of peptide vesicles: a bottom-up chemical approach. Acc Chem Res 2021;54:1934-1949. DOI |
10 | Chen IC, Hsiao LP, Huang IW, Yu HC, Yeh LC, Lin CH, et al. Phosphatidylinositol-3 kinase inhibitors, buparlisib and alpelisib, sensitize estrogen receptor-positive breast cancer cells to tamoxifen. Sci Rep 2017;7:9842. DOI |
11 | Nguyen Hoang AT, Hoe KL, Lee SJ. CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells. PLoS One 2021;16:e0246264. DOI |
12 | Friedman ZY. Recent advances in understanding the molecular mechanisms of tamoxifen action. Cancer Invest 1998;16:391-396. DOI |
13 | Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, et al. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev 2013;39:935-946. DOI |
14 | Osborne CK, Boldt DH, Clark GM, Trent JM. Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res 1983;43:3583-3585. |
15 | Baral E, Nagy E, Berczi I. Modulation of natural killer cell-mediated cytotoxicity by tamoxifen and estradiol. Cancer 1995;75:591-599. DOI |
16 | Wiseman H, Cannon M, Arnstein HR, Halliwell B. Enhancement by tamoxifen of the membrane antioxidant action of the yeast membrane sterol ergosterol: relevance to the antiyeast and anticancer action of tamoxifen. Biochim Biophys Acta 1993;1181:201-206. DOI |
17 | Gundimeda U, Chen ZH, Gopalakrishna R. Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells. J Biol Chem 1996;271:13504-13514. DOI |
18 | Chen Y, Schindler M, Simon SM. A mechanism for tamoxifen-mediated inhibition of acidification. J Biol Chem 1999;274:18364-18373. DOI |
19 | Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, et al. Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999;285:901-906. DOI |
20 | Mendes-Pereira AM, Sims D, Dexter T, Fenwick K, Assiotis I, Kozarewa I, et al. Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen. Proc Natl Acad Sci U S A 2012;109:2730-2735. DOI |
21 | Lum PY, Armour CD, Stepaniants SB, Cavet G, Wolf MK, Butler JS, et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004;116:121-137. DOI |
22 | Beggs WH. Anti-Candida activity of the anti-cancer drug tamoxifen. Res Commun Chem Pathol Pharmacol 1993;80:125-128. |
23 | Hasegawa G, Akatsuka K, Nakashima Y, Yokoe Y, Higo N, Shimonaka M. Tamoxifen inhibits the proliferation of nonmelanoma skin cancer cells by increasing intracellular calcium concentration. Int J Oncol 2018;53:2157-2166. |
24 | de Medina P, Favre G, Poirot M. Multiple targeting by the antitumor drug tamoxifen: a structure-activity study. Curr Med Chem Anticancer Agents 2004;4:491-508. DOI |
25 | Nurse P. Fission yeast cell cycle mutants and the logic of eukaryotic cell cycle control. Mol Biol Cell 2020;31:2871-2873. DOI |
26 | Wiseman H, Cannon M, Arnstein HR. Observation and significance of growth inhibition of Saccharomyces cerevisiae (A224A) by the anti-oestrogen drug tamoxifen. Biochem Soc Trans 1989;17:1038-1039. DOI |
27 | Khan SZ, Longland CL, Michelangeli F. The effects of phenothiazines and other calmodulin antagonists on the sarcoplasmic and endoplasmic reticulum Ca(2+) pumps. Biochem Pharmacol 2000;60:1797-1806. DOI |
28 | Dolan K, Montgomery S, Buchheit B, Didone L, Wellington M, Krysan DJ. Antifungal activity of tamoxifen: in vitro and in vivo activities and mechanistic characterization. Antimicrob Agents Chemother 2009;53:3337-3346. DOI |
29 | Takegawa K, Iwaki T, Fujita Y, Morita T, Hosomi A, Tanaka N. Vesicle-mediated protein transport pathways to the vacuole in Schizosaccharomyces pombe. Cell Struct Funct 2003;28:399-417. DOI |
30 | Wang CW, Klionsky DJ. The molecular mechanism of autophagy. Mol Med 2003;9:65-76. DOI |
31 | Kume K, Hashimoto T, Suzuki M, Mizunuma M, Toda T, Hirata D. Identification of three signaling molecules required for calcineurin-dependent monopolar growth induced by the DNA replication checkpoint in fission yeast. Biochem Biophys Res Commun 2017;491:883-889. DOI |
32 | Chesnel F, Couturier A, Alusse A, Gagne JP, Poirier GG, Jean D, et al. The prefoldin complex stabilizes the von Hippel-Lindau protein against aggregation and degradation. PLoS Genet 2020;16:e1009183. DOI |
33 | Taleat Z, Larsson A, Ewing AG. Anticancer drug tamoxifen affects catecholamine transmitter release and storage from single cells. ACS Chem Neurosci 2019;10:2060-2069. DOI |